SEBI v. Omaxe Limited, Rohtas Goel and others (financial statement misstatements, 2024)

Judgment entered

✓ Checked against the primary document on October 8, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, in a single reading of the order; an independent second reading of 60 SEBI records agreed on every field for 56, the four misses being penalty amounts. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sebi-85289-misleading-issuer-disclosure-2024) by email

In July 2024 a SEBI chief general manager found that real estate developer Omaxe Limited and its senior management had published misstated financial statements for the years 2018-19 to 2020-21. The order restrained the company and six executives for 2 years and imposed penalties on sixteen noticees totalling Rs 47,00,000.

The record

What was ordered

Civil penalty

—

Disgorgement

—

Prejudgment interest

—

Total relief

—

Alleged gain

—

Penalty as published

4.7m INR

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars. This regulator states penalties in INR. The figure is recorded as published and is not converted, so it does not appear in the USD totals or medians used elsewhere on this site.

What is alleged to have happened

SEBI chief general manager G. Ramar issued the final order on 30 July 2024. There were sixteen noticees: Omaxe Limited, its chairman and managing director Rohtas Goel and other executive and non-executive directors, chief financial officers and independent directors. Twelve are named on this record; four further directors are not listed here.

SEBI began with a complaint alleging fraudulent transactions, diversion of funds and inflated turnover, followed by a forensic audit covering April 2018 to March 2021. The show cause notice of August 2023 alleged that the company and its management knowingly reported false financial statements so as to maintain the share price, to the benefit of shares that had been pledged. The listed items included overstated sales to related counterparties, allegedly fictitious consultancy revenue, overstated debtors, rent and interest expenses, and wrongly classified loans.

The order finds that the executives named as noticees 2 to 6 and the company breached the fraud and unfair trade practice regulations read with section 12A of the SEBI Act, along with listing regulation obligations on accounts. For the other noticees it found failures of duty, such as independent directors and audit committee members who did not act, resulting in misleading statements being published, and breaches of the listing regulations only.

The company and noticees 1 to 6 were restrained from the securities market for 2 years, and noticees 2 to 6 were barred from director or key managerial posts in other listed companies for 2 years. Penalties were Rs 7,00,000 on Omaxe, Rs 6,00,000 each on five executives and Rs 1,00,000 each on ten other directors, Rs 47,00,000 in all.

The record does not show whether the order was appealed, whether the penalties were paid, or whether the price effect alleged in the notice was established. The order warns of prosecution for non-compliance with it but mentions no criminal case. The matter concerns published company accounts, not a trading scheme.

This library tags the matter as misleading issuer disclosure. The tagging is ours, not the regulator's.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the order.

What technique is this, and how does it work?

This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

• Misleading issuer disclosure — see how it works, what statute it engages, and every other action tagged the same way.

Timeline

1. 2024-07-30 SEBI order

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

• SEBI order
• Order (PDF)

The linked release is published by the issuing regulator under its own terms. Our summary and narrative above are our own writing.

Related actions

Other actions in the library sharing at least one technique tag with this one.

Record added October 8, 2026. submit a correction.